NEW YORK (GenomeWeb News) – Life science informatics developer BioBase said today that it will partner with InforSense to offer its products with the InforSense workflow platform.
Under the agreement, both companies’ customers will have access to BioBase’s Knowledge Library products, including Transfac, Transpath, and Proteome, on the InforSense platform.  InforSense also will make its ExPlain application available for use in high-throughput gene expression data research and in biomarker discovery.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.